A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
Clinical trial NCT06101082 · RECRUITING
Trial details
- NCT number
- NCT06101082
- Sponsor
- China Medical University, China
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-16
- Primary completion
- 2026-10-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.